Ucitech.io

Ucitech.io
Advanced navigation and search & rescue solutions for drones, automotive, and homeland security.
About
What does Ucitech.io do?
Ucitech.io provides advanced navigation and search & rescue solutions. Their technology offers accurate 3D location and identification of survivors in challenging environments, as well as reliable navigation independent of GPS signals. They serve industries including drones, automotive, and homeland security.
When was Ucitech.io founded?
Ucitech.io was founded in 2020.
What industry does Ucitech.io operate in?
Ucitech.io operates in Homeland Security, Cybersecurity, Defense Tech, Drone Technology, Automotive AI, Navigation Systems.
How many employees does Ucitech.io have?
Ucitech.io has approximately 3 people on record.
Enclave Systems provides Zero Trust Network Access (ZTNA) solutions to simplify and secure business network connectivity.
An AI image detector that identifies AI-generated images and deepfakes with high accuracy.
Acloaker is an enterprise-grade traffic protection and smart routing platform that filters bots and fraud, routes real visitors instantly, and scales campaigns with confidence.
Digital rights, online security, data leaks, and the state in the age of algorithms. Who collects our data and what to do about it.
Auspere is the security and governance control layer for agentic AI.
A production-ready, lightweight open-source virtualization platform for environments from homelabs to hyperscale infrastructure.
Actorix provides an AI-powered solution to detect and block phishing attacks before they reach users.
ShieldTrust is building the security and trust layer for AI that acts on critical systems, enabling control, enforcement, and provable trust for autonomous AI.
An entrant is a company tagged Cybersecurity whose domain was first registered in the window, counted from registry records in the StartupHub directory. 7 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.